InvestorsHub Logo
Followers 30
Posts 4098
Boards Moderated 0
Alias Born 07/25/2007

Re: sulaco post# 268934

Monday, 07/25/2016 1:02:51 PM

Monday, July 25, 2016 1:02:51 PM

Post# of 345846

Yes, there is one study with HER2+ positive receptor breast cancer, but no mention of Herceptin (which is a limited field anyway as only 20% of breast cancers express this gene receptor.)



No, it isn't 20% of breast cancers express this gene. HER positive cancers are those which exhibit high expression of HER2 as determined histochemically. It isn't an on or off situation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News